Age-Related Macular Degeneration — or ARMD — is one of the most nagging eye diseases to cause trouble later in life. In fact, the number of ARMD cases in America is expected to present in over 22 million people by the year 2050. The wet variant of ARMD is particularly dangerous, and generally requires eye injections to keep it at bay.
Nanodropper, Inc., a medical device company offering a first-of-its-kind eyedrop bottle adaptor that reduces eyedrop size, recently completed a $1.4 million seed round.
Golden Seeds joined the round, along with Minnesota-based Rochester Area Economic Development, Inc., and members of the Alliance of Angels.